Is ozanimod covered by medical insurance?

Ozamod (ozanimod) The original drug has been on the market in China, but it has been on the market for a short time. It has not been included in the scope of medical insurance through the relevant policies of the National Medical Insurance Administration. Patients cannot use medical insurance for reimbursement and purchase. The specific price is not yet clear, and domestic purchase channels are relatively difficult. Ozamod (ozanimod) is a drug used to treat multiple sclerosis (MS) and ulcerative colitis (UC). It belongs to a class of drugs called selective S1P receptor modulators. The S1P receptor is located on the surface of immune cells that play a key role in multiple sclerosis. Ozamod regulates the ability of immune cells to enter and leave lymph nodes by binding to S1P receptors, reducing the cells' attack on the central nervous system and alleviating symptoms caused by the disease.